Luke J.Burton


Los Angeles +

Luke Burton aggressively litigates intellectual property cases in a broad range of technical disciplines. He has represented clients in the software, antenna, medical device, pharmaceutical, biosimilar, and genetic engineering fields in patent litigation and related cases. Luke is experienced in matters before the International Trade Commission and the Patent Trial and Appeal Board, as well as in matters before the federal courts.

Prior to joining Jones Day, Luke practiced at several law firms that focus on IP disputes and served a clerkship in the U.S. Court of Appeals for the Federal Circuit. Before practicing law, Luke was a process engineer for one of the largest biofermentation chemical plants in the world.


  • Sloan Kettering and Juno Therapeutics win over $1.1 billion after jury verdict and post-trial motions in patent dispute with Kite Pharma/Gilead involving CAR-T therapyOn behalf of patentee Sloan Kettering Institute and exclusive licensee Juno Therapeutics (a subsidiary of Celgene Corporation, a Bristol Myers Squibb company), Jones Day and co-counsel prevailed in a jury trial that spanned eight days and involved 22 witnesses, wherein the jury awarded our clients $752 million in compensation for the infringement of their patents by Kite Pharma, Inc. (a Gilead Sciences, Inc. company) through the making and selling of its infringing CAR-T therapy, YESCARTA®.
  • Shiseido acquires Drunk Elephant™ for $845 millionJones Day advised Shiseido Americas Corporation in its $845 million acquisition of Drunk Elephant™.
  • We use cookies to deliver our online services. Details of the cookies and other tracking technologies we use and instructions on how to disable them are set out in our Cookies Policy. By using this website you consent to our use of cookies.